Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants

Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants

Abstract The COVID-19 caused by the SARS-CoV-2 virus was declared a pandemic disease in March 2020 by the World Health Organization (WHO). Structure-Based Drug Design strategies based on docking methodologies have been widely used for both new drug development and drug repurposing to find effective...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Isabella A. Guedes, Leon S. C. Costa, Karina B. dos Santos, Ana L. M. Karl, Gregório K. Rocha, Iury M. Teixeira, Marcelo M. Galheigo, Vivian Medeiros, Eduardo Krempser, Fábio L. Custódio, Helio J. C. Barbosa, Marisa F. Nicolás, Laurent E. Dardenne
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/775314e5503f4df891ef3fba94a6266e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/775314e5503f4df891ef3fba94a6266e

Ejemplares similares